Medication for Addiction Treatment During COVID-19
As overdose rates rise, we need addiction treatment in hospitals now more than ever. This guidance outlines how to implement medication for addiction treatment (MAT) during predicted COVID-19 surges.
Fighting for a Better Future
Structural Racism is a Public Health Emergency. Driving structural change to improve low barrier access to evidence-based, respectful, and responsive medical care for all people who use drugs is at the heart of our mission. Yet, we can do more.
Blueprint for Hospital Opioid Use Disorder Treatment
This comprehensive resource is scalable for any health system, based on our model implemented at diverse sites that demonstrate feasibility at large and small, public and private, urban, and rural hospitals.
Be The Changemaker: Bootcamp For Champions
11 Mar 2021, 11:00 am
Measuring and Communicating Success: Prove Impact (Session 4)
Modeled on the CA Bridge implementation Blueprint, this “Boot Camp” series will provide specialized training and networking opportunities for hospital champions. Sessions will focus on changing the standard of care for substance use disorders, including clinical guidance for medication for addiction treatment (MAT), and health equity for underrepresented populations.
This series offers CME for physicians and self-reported hours for other clinicians.